Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease

Clinical trial NCT02458014 · COMPLETED

Trial details

NCT number: NCT02458014
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Acute Lymphoblastic Leukemia in Complete Remission B Acute Lymphoblastic Leukemia Minimal Residual Disease Philadelphia Chromosome Positive

Start date: 2015-09-14
Primary completion: 2025-09-16
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.